Literature DB >> 33481908

In situ kinetic measurements of α-synuclein aggregation reveal large population of short-lived oligomers.

Enrico Zurlo1, Pravin Kumar1, Georg Meisl2, Alexander J Dear2, Dipro Mondal1, Mireille M A E Claessens3, Tuomas P J Knowles2,4, Martina Huber1.   

Abstract

Knowledge of the mechanisms of assembly of amyloid proteins into aggregates is of central importance in building an understanding of neurodegenerative disease. Given that oligomeric intermediates formed during the aggregation reaction are believed to be the major toxic species, methods to track such intermediates are clearly needed. Here we present a method, electron paramagnetic resonance (EPR), by which the amount of intermediates can be measured over the course of the aggregation, directly in the reacting solution, without the need for separation. We use this approach to investigate the aggregation of α-synuclein (αS), a synaptic protein implicated in Parkinson's disease and find a large population of oligomeric species. Our results show that these are primary oligomers, formed directly from monomeric species, rather than oligomers formed by secondary nucleation processes, and that they are short-lived, the majority of them dissociates rather than converts to fibrils. As demonstrated here, EPR offers the means to detect such short-lived intermediate species directly in situ. As it relies only on the change in size of the detected species, it will be applicable to a wide range of self-assembling systems, making accessible the kinetics of intermediates and thus allowing the determination of their rates of formation and conversion, key processes in the self-assembly reaction.

Entities:  

Year:  2021        PMID: 33481908      PMCID: PMC7822277          DOI: 10.1371/journal.pone.0245548

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  44 in total

Review 1.  Hunting the chameleon: structural conformations of the intrinsically disordered protein alpha-synuclein.

Authors:  Malte Drescher; Martina Huber; Vinod Subramaniam
Journal:  Chembiochem       Date:  2012-03-21       Impact factor: 3.164

2.  Molecular mechanisms of protein aggregation from global fitting of kinetic models.

Authors:  Georg Meisl; Julius B Kirkegaard; Paolo Arosio; Thomas C T Michaels; Michele Vendruscolo; Christopher M Dobson; Sara Linse; Tuomas P J Knowles
Journal:  Nat Protoc       Date:  2016-01-07       Impact factor: 13.491

3.  Quantitative morphological analysis reveals ultrastructural diversity of amyloid fibrils from alpha-synuclein mutants.

Authors:  Martijn E van Raaij; Ine M J Segers-Nolten; Vinod Subramaniam
Journal:  Biophys J       Date:  2006-09-22       Impact factor: 4.033

4.  Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates.

Authors:  Ioana M Ilie; Amedeo Caflisch
Journal:  Chem Rev       Date:  2019-04-11       Impact factor: 60.622

5.  Fibril breaking accelerates α-synuclein fibrillization.

Authors:  Volodymyr V Shvadchak; Mireille M A E Claessens; Vinod Subramaniam
Journal:  J Phys Chem B       Date:  2015-01-27       Impact factor: 2.991

6.  α-Synuclein aggregation at low concentrations.

Authors:  Kseniia Afitska; Anna Fucikova; Volodymyr V Shvadchak; Dmytro A Yushchenko
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2019-05-13       Impact factor: 3.036

7.  Conformational properties of alpha-synuclein in its free and lipid-associated states.

Authors:  D Eliezer; E Kutluay; R Bussell; G Browne
Journal:  J Mol Biol       Date:  2001-04-06       Impact factor: 5.469

8.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

9.  Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation.

Authors:  Serene W Chen; Srdja Drakulic; Emma Deas; Myriam Ouberai; Francesco A Aprile; Rocío Arranz; Samuel Ness; Cintia Roodveldt; Tim Guilliams; Erwin J De-Genst; David Klenerman; Nicholas W Wood; Tuomas P J Knowles; Carlos Alfonso; Germán Rivas; Andrey Y Abramov; José María Valpuesta; Christopher M Dobson; Nunilo Cremades
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-08       Impact factor: 11.205

10.  α-Synuclein-Confocal Nanoscanning (ASYN-CONA), a Bead-Based Assay for Detecting Early-Stage α-Synuclein Aggregation.

Authors:  Irene Pérez-Pi; David A Evans; Mathew H Horrocks; Nhan T Pham; Karamjit S Dolt; Joanna Koszela; Tilo Kunath; Manfred Auer
Journal:  Anal Chem       Date:  2019-04-18       Impact factor: 6.986

View more
  4 in total

1.  Using a Caenorhabditis elegans Parkinson's Disease Model to Assess Disease Progression and Therapy Efficiency.

Authors:  Samantha Hughes; Maritza van Dop; Nikki Kolsters; David van de Klashorst; Anastasia Pogosova; Anouk M Rijs
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-22

2.  Mechanisms of enhanced aggregation and fibril formation of Parkinson's disease-related variants of α-synuclein.

Authors:  Takashi Ohgita; Norihiro Namba; Hiroki Kono; Toshinori Shimanouchi; Hiroyuki Saito
Journal:  Sci Rep       Date:  2022-04-26       Impact factor: 4.996

3.  Molecular mechanism for the synchronized electrostatic coacervation and co-aggregation of alpha-synuclein and tau.

Authors:  Pablo Gracia; David Polanco; Jorge Tarancón-Díez; Ilenia Serra; Maruan Bracci; Javier Oroz; Douglas V Laurents; Inés García; Nunilo Cremades
Journal:  Nat Commun       Date:  2022-08-06       Impact factor: 17.694

4.  Cellular Therapy Using Epitope-Imprinted Composite Nanoparticles to Remove α-Synuclein from an In Vitro Model.

Authors:  Mei-Hwa Lee; Jeng-Shiung Jan; James L Thomas; Yuan-Pin Shih; Jin-An Li; Chien-Yu Lin; Tooru Ooya; Lilla Barna; Mária Mészáros; András Harazin; Gergő Porkoláb; Szilvia Veszelka; Maria A Deli; Hung-Yin Lin
Journal:  Cells       Date:  2022-08-19       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.